COVID-19 can make arthritis worse, both by triggering flares in people who already have the condition and by causing new joint inflammation in people who never had arthritis before. The connection is rooted in the intense immune response the virus provokes, which floods the body with the same inflammatory molecules that drive arthritis pain and swelling. Whether you have rheumatoid arthritis, osteoarthritis, or no prior joint problems at all, a COVID infection can leave your joints in noticeably worse shape for weeks or months afterward.
Why COVID Fuels Joint Inflammation
When your body fights off SARS-CoV-2, it ramps up production of a cascade of inflammatory signaling molecules. Among the most prominent are IL-6, IL-1, IL-17, and TNF, all of which play central roles in arthritis. In severe COVID cases, this response can spiral into what’s called a cytokine storm, where the immune system overshoots so dramatically that it damages the body’s own tissues. Even in milder infections, these inflammatory signals circulate through the bloodstream and can settle into joints, amplifying existing inflammation or sparking new problems.
This isn’t unique to COVID. Roughly 1% of all cases of acute inflammatory arthritis are estimated to follow upper respiratory viral infections. But COVID appears to be an especially potent trigger because of the scale and duration of the immune response it generates. The same inflammatory pathways targeted by common arthritis medications (like drugs that block IL-6 or TNF) are the ones COVID activates most aggressively.
Rheumatoid Arthritis Flares After Infection
If you have rheumatoid arthritis, a COVID infection creates a double problem. First, the virus itself floods your system with the exact inflammatory molecules your disease already overproduces. Second, certain medications you may be taking need to be paused during an active infection, which can leave your arthritis less controlled at the worst possible time.
Guidelines from the American College of Rheumatology recommend temporarily stopping most biologic and targeted therapies during a confirmed COVID infection. Standard medications like methotrexate and leflunomide should also be paused while you’re actively infected. Low-dose steroids, however, should not be stopped abruptly, because suddenly withdrawing them during a stressful illness can cause additional complications. NSAIDs like ibuprofen can generally continue unless COVID causes serious kidney, heart, or gastrointestinal problems. The European Alliance of Associations for Rheumatology recommends discussing any medication changes on a case-by-case basis with your rheumatologist, particularly for mild infections.
The result of pausing treatment while your body is in an inflammatory overdrive is predictable: many people experience a noticeable arthritis flare during or shortly after their COVID infection. Getting back on your medications after recovery is critical, and your rheumatologist can help you determine the right timing.
Effects on Osteoarthritis
Osteoarthritis, the wear-and-tear form of joint disease, is affected differently but still worsened by COVID. Research published in MDPI found that the musculoskeletal symptoms of long COVID closely resemble characteristics of accelerated joint aging. The virus appears to contribute to changes in connective tissues, bone mineral density, and joint health that mirror the early stages of osteoarthritis.
Specifically, COVID can cause vitamin D deficiency, increased bone fragility, and calcium loss, all of which worsen the structural decline that drives osteoarthritis pain. The virus does this partly through its effects on cells lining blood vessels and fat tissue, which are involved in early aging processes. While osteoarthritis isn’t an autoimmune disease like rheumatoid arthritis, the systemic inflammation from COVID still reaches the joints, and the downstream effects on bone and cartilage health can push osteoarthritis symptoms forward faster than they would otherwise progress.
New Joint Problems After COVID
Some people develop inflammatory arthritis for the first time after recovering from COVID, typically appearing several weeks after the acute infection clears. This can take one of two forms: reactive arthritis, where the immune system’s post-infection activity causes joint inflammation, or the unmasking of rheumatoid arthritis that may have been developing silently.
Reactive arthritis tends to affect people under 50 and develops as the immune system continues fighting even after the virus itself is gone. There’s no definitive lab test for it. Diagnosis is based on clinical assessment after ruling out other causes of joint pain. In case series documenting these patients, some showed elevated inflammatory markers and antibodies consistent with rheumatoid arthritis, suggesting the infection tipped a pre-existing tendency into full-blown disease. Women and older adults appear to be at higher risk for developing new inflammatory arthritis after viral respiratory infections.
The distinction matters because reactive arthritis often resolves over time, while rheumatoid arthritis triggered by COVID typically requires ongoing treatment. If you develop persistent joint pain, swelling, or stiffness in the weeks following a COVID infection, getting evaluated early can help determine which path you’re on.
Joint Pain as Part of Long COVID
Joint and muscle pain is one of the commonly reported symptoms of long COVID, according to the CDC. These symptoms can last weeks, months, or even years after the initial illness, and they follow an unpredictable pattern. Pain can emerge, resolve, and then return over different stretches of time. For people with pre-existing arthritis, this makes it difficult to distinguish a true disease flare from long COVID symptoms layered on top of their baseline condition.
The overlap between long COVID joint pain and arthritis-related joint pain is significant enough that researchers have described the musculoskeletal effects of long COVID as an “early osteoarthritis-like phenotype,” meaning the symptoms and underlying tissue changes look remarkably similar to what happens in early-stage osteoarthritis. This doesn’t mean COVID gives you osteoarthritis overnight, but it does suggest the virus can accelerate processes that were already underway or plant the seeds for joint problems down the road.
What About Vaccination and Flares?
A meta-analysis published in Frontiers in Immunology found that about 14.4% of people with inflammatory arthritis experienced a disease flare within one month of COVID vaccination. The rate was 9.1% for rheumatoid arthritis patients and 5.3% for those with a related condition called spondyloarthritis. Flares lasted at least two days and were significant enough to require a change in treatment.
While a 14% flare rate is not trivial, it’s worth weighing against what happens with actual COVID infection, which triggers a far more intense and prolonged inflammatory response. A brief, manageable flare from vaccination is generally a smaller burden than the sustained immune activation and potential medication disruptions that come with a full COVID infection. If you’ve experienced a post-vaccination flare before, your rheumatologist can help you plan around future doses, sometimes by adjusting the timing of your regular medications.
Who Is Most at Risk
The people most likely to see their arthritis worsen after COVID include those with active or poorly controlled inflammatory arthritis at baseline, those on immunosuppressive medications that need to be paused during infection, women, and older adults. Preliminary evidence suggests that the immune-mediated aftermath of COVID not only worsens existing inflammatory joint diseases but can also precipitate them in people who were predisposed but hadn’t yet developed symptoms.
If you have arthritis and contract COVID, tracking your joint symptoms closely during and after recovery gives you and your doctor useful information. New or worsening joint swelling, prolonged morning stiffness, or pain that doesn’t improve as your respiratory symptoms resolve all warrant follow-up, particularly in the weeks and months after infection when post-COVID inflammatory arthritis is most likely to emerge.